Mortality outcomes in hospitalized oncology patients after rapid response team activationDecember 6, 2018Patient & Survivor Care
Effectiveness of duloxetine in treatment of painful chemotherapy-induced peripheral neuropathy: a systematic reviewDecember 6, 2018Patient & Survivor Care
Development, implementation, and evaluation of a prostate cancer supportive care programDecember 6, 2018Genitourinary Cancer
Symptom burdens related to chemotherapy-induced anemia in stage IV cancerDecember 5, 2018Patient & Survivor CareBreast CancerLung CancerLymphoma & Plasma Cell Disorders
2018: A banner year for hematology drug approvalsDecember 5, 2018Business of MedicineMixed TopicsLymphoma & Plasma Cell DisordersRare Diseases
CLL resistance mechanism to venetoclax identifiedDecember 5, 2018Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell Disorders
In IDH-mutated AML, first-line IDH inhibitors plus chemo may boost remissionDecember 5, 2018Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell Disorders
Patterns of malignancies in patients with HIV-AIDS: a single institution observational studyNovember 27, 2018Patient & Survivor CareSarcoma & GISTGynecologic CancerLymphoma & Plasma Cell Disorders
Malignant olecranon bursitis in the setting of multiple myeloma relapseNovember 26, 2018Lymphoma & Plasma Cell DisordersPatient & Survivor Care
Immunotherapy may hold the key to defeating virally associated cancersNovember 25, 2018Head & Neck/Thyroid CancersGenitourinary CancerGynecologic CancerGastroenterologyImmunotherapyLeukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell Disorders
A ‘double-hit’ bone marrow rare co-occurrence of 2 different pathologiesNovember 13, 2018Lymphoma & Plasma Cell Disorders
Collaboration is key to bridging the AYA cancer care divideOctober 31, 2018Patient & Survivor CarePediatrics
